ASX Announcements
Vicinity Centres (ASX: VCX) – Vicinity Centres Files 2025 Annual Report
Vicinity Centres has delivered a strong 49% increase in funds from operations for FY26 to $1,004.6 million, a performance that underpins...
Dexus (ASX: DXS) – Dexus Files 2026 Annual Report
Dexus has reported a mixed set of results for the year ended 30 June 2026, with revenue falling 25.4% to $710.0 million while statutory profit...
TELIX Pharmaceuticals (ASX: TLX) – Telix Releases HY26 Results Presentation
I need the actual announcement content to write this properly. The text you've provided contains only the title page and forward-looking statement...
Cuscal (ASX: CCL) – Cuscal Files FY26 Results Presentation
I notice the announcement text you've provided contains only the cover page and legal disclaimers—there are no actual financial results, metrics, or...
TELIX Pharmaceuticals (ASX: TLX) – Telix Announces Half Year 2026 Results
Telix Pharmaceuticals delivered strong H1 2026 results that underscore the company's ability to execute commercially while advancing a late-stage...
Cuscal (ASX: CCL) – Cuscal Reports FY26 Full Year Results
Cuscal Limited reported a 49% increase in statutory net profit after tax to $42.7 million for FY26, though this headline figure reflects a...
TELIX Pharmaceuticals (ASX: TLX) – Files HY26 Interim Report and Appendix 4D
Telix Pharmaceuticals has swung to a half-year profit of $38.3 million, compared with a loss of $2.3 million in the prior year period, marking a...
Cuscal (ASX: CCL) – Cuscal Files FY2026 Annual Report
Cuscal Limited delivered robust profit growth in FY26, with net profit after tax jumping 48.8% to $42.7 million from $28.7 million in the prior...
IPH (ASX: IPH) – IPH Reports FY2026 Full Year Results
IPH Limited delivered a 16.9% increase in net profit after tax to $80.4m for the financial year ended 30 June 2026, a standout result that masks an...
IPH (ASX: IPH) – IPH FY26 Results Investor Presentation
I can see the announcement text you've provided covers the presentation cover page, disclaimer, table of contents, and IPH's company overview—but it...